Conflict of Interest

Advances in Social Sciences Research Journal

Conflict of Interest Policy

What authors, reviewers and editors must declare as competing interests at ASSRJ, and how undeclared conflicts are handled.

A conflict of interest exists when professional judgement concerning a primary interest (such as the validity of research) may be influenced by a secondary interest (such as financial or personal gain). Declaring conflicts does not imply wrongdoing — but failing to declare them does. This policy applies to authors, reviewers and editors.

What must be declared

Conflicts may be financial or non-financial, including but not limited to:

employment, consultancies, honoraria, paid expert testimony or advisory roles;
grants, stock or share ownership, patents or royalties;
membership of boards or organisations with an interest in the work; and
close personal or family relationships, academic rivalry, advocacy roles, or strongly held beliefs relevant to the subject.

In the social sciences, also consider funding or sponsorship from organisations with a stake in the findings, and a close relationship with a community or institution being studied.

Authors

Authors must include a Conflict of Interest statement declaring all relevant interests of every author, or stating: “The authors declare no conflicts of interest.” All funding sources must also be disclosed. Undeclared conflicts discovered after publication may lead to a correction or, in serious cases, retraction.

Reviewers

Reviewers must decline to review, or promptly inform the editor, where they have a conflict — for example recent collaboration or rivalry with the authors, a financial interest in the outcome, or any relationship that could bias their assessment.

Editors

Editors must not handle manuscripts in which they have a competing interest, including those authored by themselves, close colleagues or collaborators; such manuscripts are reassigned. Editorial Board members’ submissions are subject to the same independent process as any other and receive no preferential treatment.